Abstract | BACKGROUND: To determine whether the presence of a capsule regulator gene [i.e., regulator of mucoid phenotype A (rmpA) gene] contributes to virulence on extended-spectrum β-lactamase-producing Klebsiella pneumoniae (ESBL-KP) with serotype non-K1/K2 strains. METHODS: Twenty-eight ESBL-KP and non-ESBL-KP isolates were collected from the Tri-Service General Hospital (Taipei, Taiwan). The impact of the virulent rmpA gene in different capsular polysaccharide serotypes on ESBL-KP and non-ESBL-KP isolates was studied by a neutrophil phagocytosis reaction, a serum bactericidal assay, and an animal survival model. RESULTS: Resistance to broad spectrum antibiotics was more prevalent in ESBL-KP strains than in non-ESBL-KP strains (p < 0.01). The ESBL-KP strains had different molecular patterns from non-ESBL-KP strains, based on pulsed-field gel electrophoresis. The frequency of serum-resistant isolates was the highest among ESBL-KP strains with rmpA (i.e., rmpA(+)) [71.4% (5/7)] than among of non-ESBL-KP rmpA(+) strains [42.8% (6/14)], ESBL-KP strains without rmpA (rmpA(-)) [33.3% (7/21)], and non-ESBL-KP rmpA(-) strains [14.2% (2/14)]. The most significant increase in neutrophil resistance occurred in the ESBL-KP rmpA(+) strains in comparison to the non-ESBL-KP rmpA(+), ESBL-KP rmpA(-), and non-ESBL-KP rmpA(-) strains (p < 0.01). The results of the animal survival model were compatible with the neutrophil phagocytosis reaction and serum bactericidal assay. CONCLUSION: We conclude that the pathogenic potential is greater in rmpA(+) ESBL-KP strains than in rmpA(-) ESBL-KP and non-ESBL-KP strains.
|
Authors | Hsin-An Lin, Ya-Li Huang, Kao-Ming Yeh, L K Siu, Jung-Chung Lin, Feng-Yee Chang |
Journal | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
(J Microbiol Immunol Infect)
Vol. 49
Issue 4
Pg. 494-501
(Aug 2016)
ISSN: 1995-9133 [Electronic] England |
PMID | 25442871
(Publication Type: Journal Article)
|
Copyright | Copyright © 2014. Published by Elsevier B.V. |
Chemical References |
- Anti-Bacterial Agents
- Bacterial Proteins
- RmpA protein, Klebsiella pneumoniae
- beta-Lactamases
|
Topics |
- Animals
- Anti-Bacterial Agents
(therapeutic use)
- Bacterial Capsules
(genetics)
- Bacterial Proteins
(genetics)
- Electrophoresis, Gel, Pulsed-Field
- Humans
- Klebsiella Infections
(drug therapy)
- Klebsiella pneumoniae
(drug effects, genetics, pathogenicity)
- Male
- Mice
- Mice, Inbred BALB C
- Neutrophils
(immunology)
- Phagocytosis
(genetics, immunology)
- Serogroup
- Taiwan
- beta-Lactamases
(genetics)
|